MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis

• Published in: Journal of clinical pharmacology Vol. 62; no. 4; p. 463
• Main Authors: Smith, Kimberly W, Sicignano, Dakota J, Hernandez, Adrian V, White, C Michael
• Format: Journal Article
• Language: English
• Published: England 01.04.2022
• Subjects: Combined Modality Therapy; Humans; N-Methyl-3,4-methylenedioxyamphetamine - adverse effects; N-Methyl-3,4-methylenedioxyamphetamine - therapeutic use; Psychotherapy; Stress Disorders, Post-Traumatic - drug therapy; Stress Disorders, Post-Traumatic - psychology; Treatment Outcome; drug development; clinical pharmacology; CPH; drug abuse; psychiatry (PSY); psychopharmacology (PSP)

This article discusses current literature on the use of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in the treatment of posttraumatic stress disorder (PTSD). MDMA, the intended active ingredient in illicit Ecstasy or Molly products, is a psychedelic that causes an elevated mood,...